Aging-related correlation of insulin-degrading enzyme with γ-secretase-generated products involving insulin and glucose levels in transgenic mice

Neurochemical Research

Volumn 30, Issue 9, 2005, Pages 1171-1177

  Hwang, Dae Y ^a   Cho, Jung S ^a   Kim, Chuel K ^a   Shim, Sun B ^a   Jee, Seung W ^a   Lee, Su H ^a   Seo, Su J ^a   Cho, Joon Y ^b   Lee, Seok H ^a   Kim, Yong K ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Korea National Sport University   (South Korea)

Author keywords

secretase; A ; AICD; Alzheimer; Glucose; IDE; Insulin; Transgenic

Indexed keywords

GAMMA SECRETASE; GLUCOSE; INSULIN; INSULINASE; MUTANT PROTEIN; NEURON SPECIFIC ENOLASE; PRESENILIN 2;

AGING; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AGING; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; BLOOD GLUCOSE; BRAIN; ENDOPEPTIDASES; HUMANS; INSULIN; INSULYSIN; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; PRESENILIN-2;

ANIMALIA; MUS MUSCULUS;

EID: 27844488026     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-7952-7     Document Type: Article

References (19)

1. C. Glabe 2000 Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation? Nat. med. 6 133 134
2. A. B. Becker R. A. Roth 1995 Insulysin and pitrilysin: Insulin-degrading enzymes of mammals and bacteria Methods Enzymol. 248 693 703
3. D. Edbauer M. Willem S. Lammich H. Steiner C. Haass 2002 Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD) J. Biol. Chem. 277 13389 13393
4. W. C. Duckworth R. G. Bennett F. G. Hamel 1998 Insulin degradation: Progress and potential Endocr. Rev. 19 608 624
5. I. D. Goldfine J. A. Williams A. C. Bailey K. Y. Wong Y. Iwamoto K. Yokono S. Baba R. A. Roth 1984 Degradation of insulin by isolated mouse pancreatic acini. Evidence for cell surface protease activity Diabetes 33 64 72
6. K. A. Seta R. A. Roth 1997 Overexpression of insulin-degrading enzyme: Cellular localization and effects on insulin signaling Biochem. Biophys. Res. Commun. 231 167 171
7. K. Vekrellis Z. Ye W. Q. Qiu D. Walsh V. Chesneau M. R. Rosner D. J. Selkoe 2000 Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme J. Neurosci. 20 1657 1665
8. A. N. Sabirov Y. E. Kim H. J. Kim V. V. Samukov 1998 FMOC- and NSC-groups as a base labile N(α)-amino protection: A comparative study in the automated SPPS Protein Peptide Lett. 5 57 62
9. N. Ida T. Hartmann J. Pantel J. Schroder R. Zerfass H. Forsti R. Sandbrink C. L. Masters K. Beyreuther 1996 Analysis of heterogeneous A4 peptide in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay J. Biol. Chem. 271 22908 22914
10. D. Y. Hwang K. R. Chae T. S. Kang J. H. Hwang C. H. Lim H. K. Kang J. S. Goo M. R. Lee H. J. Lim S. H. Min J. Y. Cho J. T. Hong C. W. Song S. G. Paik J. S. Cho Y. K. Kim 2002 Alterations in behavior, amyloid β-42, caspase-3, and Cox-2 in mutant PS2 transgenic mouse model of Alzheimer's disease FASEB J. 16 805 813
11. W. Xia W. J. Ray B. L. Ostaszewski T. Rahmati W. T. Kimberly M. S. Wolfe J. Zhang A. M. Goate D. J. Selkoe 2000 Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation Proc. Natl. Acad. Sci. USA 97 9299 9304
12. J. Y. Cho D. Y. Hwang T. S. Kang D. H. Shin J. H. Hwang C. H. Lim S. H. Lee H. J. Lim S. H. Min S. J. Seo Y. S. Song K. T. Nam K. S. Lee J. S. Cho Y. K. Kim 2003 Use of NSE/PS2m-transgenic mice in the study of the protective effect of exercise on Alzheimer's disease J. Sports Sci. 21 943 951
13. N. Iwata Y. Takaki S. Fukami S. Tsubuki T. C. Saido 2002 Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging J. Neurosci. Res. 70 493 500
14. M. Mohajeri M. A. Wollmer R. M. Nitsch 2002 Aβ-42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo J. Biol. Chem. 277 35460 35465
15. W. Farris S. Mansourian Y. Chang L. Lindsley E. A. Eckman M. P. Frosch C. B. Eckman R. E. Tanzi D. J. Selkoe S. Guenette 2003 Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta- amyloid precursor protein intracellular domain in vivo Proc. Natl. Acad. Sci. USA 100 4162 4167
16. D. Scheuner C. Eckman M. Jensen X. Song M. Citron 1996 Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease Nat. Med. 2 864 870
17. R. P. Stolk M. M. Breteler A. Ott H. A. Pols H. W. Lamberts D. E. Globbee A. Hofman 1997 Insulin and cognitive function in an elderly population. The Rotterdam Study Diabetes Care. 20 792 795
18. G. Razay G. K. Wilcock 1994 Hyperinsulinaemia and Alzheimer's disease Age Ageing 23 396 399
19. Y. Fujisawa K. Sasaki K. Akiyama 1991 Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type Biol. Psychia. 30 1219 1228